Shares of N4 Pharma Plc (LON:N4P – Get Free Report) rose 3% during trading on Thursday . The stock traded as high as GBX 0.90 ($0.01) and last traded at GBX 0.85 ($0.01). Approximately 649,204 shares traded hands during trading, a decline of 47% from the average daily volume of 1,224,113 shares. The stock had previously closed at GBX 0.83 ($0.01).
N4 Pharma Stock Performance
The company has a market cap of £2.28 million, a price-to-earnings ratio of -120.00 and a beta of -0.03. The company has a current ratio of 27.88, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62. The firm’s 50-day moving average price is GBX 0.74 and its 200 day moving average price is GBX 0.83.
About N4 Pharma
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Read More
- Five stocks we like better than N4 Pharma
- Financial Services Stocks Investing
- MarketBeat Week in Review – 4/15 – 4/19
- What is a Dividend King?
- Comprehensive Analysis of PayPal Stock
- How Can Investors Benefit From After-Hours Trading
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
